2021
DOI: 10.3389/fchem.2021.761609
|View full text |Cite
|
Sign up to set email alerts
|

Currently Available Strategies for Target Identification of Bioactive Natural Products

Abstract: In recent years, biologically active natural products have gradually become important agents in the field of drug research and development because of their wide availability and variety. However, the target sites of many natural products are yet to be identified, which is a setback in the pharmaceutical industry and has seriously hindered the translation of research findings of these natural products as viable candidates for new drug exploitation. This review systematically describes the commonly used strategi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 146 publications
(139 reference statements)
0
14
0
Order By: Relevance
“…However, 6-chloro and 6-methoxy analogues (29−30) showed a slight decreased potency in MIA PaCa-2 cells. In addition, inserting a CH 2 CH 2 O fragment between quinoline and 6-fluoro of 23 retained the cytotoxicity (35). These fluorinated compounds (e.g., 17, 23, and 35) have the potential for developing F-radiolabeled PET imaging ligands.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, 6-chloro and 6-methoxy analogues (29−30) showed a slight decreased potency in MIA PaCa-2 cells. In addition, inserting a CH 2 CH 2 O fragment between quinoline and 6-fluoro of 23 retained the cytotoxicity (35). These fluorinated compounds (e.g., 17, 23, and 35) have the potential for developing F-radiolabeled PET imaging ligands.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…Phenotypic screening campaigns are especially suited to produce multi-targeted agents with polypharmacology. A disadvantage of phenotypic screen lies in the challenges in establishing the true direct target(s) of the identified lead inhibitors. Numerous technologies have been established throughout the years for target identification. Unfortunately, all these methods demand extensive time, resources, and sophisticated instrumentation .…”
Section: Introductionmentioning
confidence: 99%
“…[98] In addition to endogenous metabolites, ABPP is a powerful strategy for target identification of natural products. [99] Nomura and colleagues applied the competitive isoTOP-ABPP to profile targets of anti-cancer natural products including nimbolide [100] and withaferin A. [101] Nimbolide was discovered to target an E3 ubiquitin ligase RNF114, which was further furnished for target protein degradation.…”
Section: Development Of Methods Derived From Isotop-abppmentioning
confidence: 99%
“…In addition to endogenous metabolites, ABPP is a powerful strategy for target identification of natural products [99] . Nomura and colleagues applied the competitive isoTOP‐ABPP to profile targets of anti‐cancer natural products including nimbolide [100] and withaferin A [101] .…”
Section: The “Competitive” Isotop‐abppmentioning
confidence: 99%
“…Target identification is one of the most crucial steps in drug development. In the past, various strategies for the characterization of drug targets were developed [ 80 , 81 , 82 , 83 ]. These include genomic approaches, phenotypic profiling/screening and biochemical strategies.…”
Section: Secondary Screening: Target-based Assaysmentioning
confidence: 99%